Business Description
Global Medical REIT Inc
NAICS : 525920
SIC : 6798
ISIN : US37954A2042
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.46 | |||||
Debt-to-Equity | 1.06 | |||||
Debt-to-EBITDA | 5.54 | |||||
Interest Coverage | 1.23 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -0.11 | |||||
Beneish M-Score | -2.82 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.1 | |||||
3-Year EBITDA Growth Rate | 14.1 | |||||
3-Year Book Growth Rate | 1.2 | |||||
Future 3-5Y Total Revenue Growth Rate | -1.3 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 30 | |||||
9-Day RSI | 33.24 | |||||
14-Day RSI | 35.28 | |||||
6-1 Month Momentum % | -3.64 | |||||
12-1 Month Momentum % | -8 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.02 | |||||
Quick Ratio | 0.02 | |||||
Days Sales Outstanding | 19.22 | |||||
Days Payable | 176.66 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 10.41 | |||||
Dividend Payout Ratio | 15.85 | |||||
3-Year Dividend Growth Rate | 1.6 | |||||
Forward Dividend Yield % | 10.41 | |||||
5-Year Yield-on-Cost % | 11.05 | |||||
3-Year Average Share Buyback Ratio | -9.9 | |||||
Shareholder Yield % | 13.87 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 80.07 | |||||
Operating Margin % | 26.87 | |||||
Net Margin % | 14.63 | |||||
FCF Margin % | 41.43 | |||||
ROE % | 3.37 | |||||
ROA % | 1.55 | |||||
ROIC % | 1.99 | |||||
ROC (Joel Greenblatt) % | 684.14 | |||||
ROCE % | 7.53 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-FFO | 9.12 | |||||
PE Ratio | 35.04 | |||||
Forward PE Ratio | 325.8 | |||||
PE Ratio without NRI | 152.08 | |||||
PS Ratio | 3.77 | |||||
PB Ratio | 1.04 | |||||
Price-to-Tangible-Book | 1.21 | |||||
Price-to-Free-Cash-Flow | 9.09 | |||||
Price-to-Operating-Cash-Flow | 7.79 | |||||
EV-to-EBIT | 23.11 | |||||
EV-to-EBITDA | 10.89 | |||||
EV-to-Forward-EBITDA | 15.3 | |||||
EV-to-Revenue | 8.63 | |||||
EV-to-Forward-Revenue | 9.87 | |||||
EV-to-FCF | 20.82 | |||||
Price-to-Graham-Number | 2.86 | |||||
Earnings Yield (Greenblatt) % | 4.33 | |||||
FCF Yield % | 11.05 | |||||
Forward Rate of Return (Yacktman) % | -37.61 |